Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

Suprapubic versus urethral catheter drainage in robotic-assisted laparoscopic prostatectomy: advancing systematic review quality.

Hwang EC, Risk MC, Dahm P.

World J Urol. 2018 Jul 13. doi: 10.1007/s00345-018-2372-x. [Epub ahead of print] No abstract available.

PMID:
30006909
2.

Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).

Goldkuhle M, Dimaki M, Gartlehner G, Monsef I, Dahm P, Glossmann JP, Engert A, von Tresckow B, Skoetz N.

Cochrane Database Syst Rev. 2018 Jul 12;7:CD012556. doi: 10.1002/14651858.CD012556.pub2. [Epub ahead of print] Review.

PMID:
30001476
3.

Alpha-blockers for uncomplicated ureteral stones: a clinical practice guideline.

Vermandere M, Kuijpers T, Burgers JS, Kunnamo I, van Lieshout J, Wallace E, Vlayen J, Schoenfeld E, Siemieniuk RA, Trevena L, Zhu X, Verermen F, Neuschwander B, Dahm PH, Tikkinen KAO, Aubrey-Bassler K, Vernooij RWM, Aertgeerts B, Bekkering GE.

BJU Int. 2018 Jul 11. doi: 10.1111/bju.14457. [Epub ahead of print]

PMID:
29993174
4.

Medical Expulsive Therapy for Ureteral Stones-Stone Age Medicine.

Dahm P, Hollingsworth JM.

JAMA Intern Med. 2018 Jun 18. doi: 10.1001/jamainternmed.2018.2265. [Epub ahead of print] No abstract available.

PMID:
29913003
5.

Evaluation of the cost-effectiveness of buprenorphine in treatment of chronic pain using competing EQ-5D weights.

Norrlid H, Dahm P, Tennvall GR.

Scand J Pain. 2015 Jan 1;6(1):24-30. doi: 10.1016/j.sjpain.2014.07.002.

PMID:
29911578
6.

Primary cryotherapy for localised or locally advanced prostate cancer.

Jung JH, Risk MC, Goldfarb R, Reddy B, Coles B, Dahm P.

Cochrane Database Syst Rev. 2018 May 30;5:CD005010. doi: 10.1002/14651858.CD005010.pub3. Review.

PMID:
29845595
7.

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline.

Foster HE, Barry MJ, Dahm P, Gandhi MC, Kaplan SA, Kohler TS, Lerner LB, Lightner DJ, Parsons JK, Roehrborn CG, Welliver C, Wilt TJ, McVary KT.

J Urol. 2018 Jun 11. pii: S0022-5347(18)43201-6. doi: 10.1016/j.juro.2018.05.048. [Epub ahead of print]

PMID:
29775639
8.

No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.

Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T, Rogers W, Cook J, Kolias AG, Agha R, Dahm P, Sedrakyan A, McCulloch P.

Ann Surg. 2018 Apr 24. doi: 10.1097/SLA.0000000000002794. [Epub ahead of print]

PMID:
29697448
9.

Advancing Canadian Urological Association guidelines using GRADE.

Dahm P, Lewis J, Sultan S.

Can Urol Assoc J. 2018 Apr;12(4):93-94. doi: 10.5489/cuaj.5270. Epub 2017 Dec 22. No abstract available.

10.

A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer.

Goldkuhle M, Narayan VM, Weigl A, Dahm P, Skoetz N.

BMJ Open. 2018 Mar 25;8(3):e020869. doi: 10.1136/bmjopen-2017-020869.

11.

The fragility of statistically significant findings from randomised controlled trials in the urological literature.

Narayan VM, Gandhi S, Chrouser K, Evaniew N, Dahm P.

BJU Int. 2018 Jul;122(1):160-166. doi: 10.1111/bju.14210. Epub 2018 Apr 24.

PMID:
29569390
12.

The promise of new urological procedures and medications to manage lower urinary tract symptoms related to benign prostatic obstruction.

Dahm P, Jung JH.

Curr Opin Urol. 2018 May;28(3):260-261. doi: 10.1097/MOU.0000000000000493. No abstract available.

PMID:
29538169
13.

Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study.

Liu W, Antonelli PJ, Dahm P, Gerhard T, Delaney JAC, Segal R, Crystal S, Winterstein AG.

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):587-595. doi: 10.1002/pds.4405. Epub 2018 Mar 7.

PMID:
29512263
14.

Desmopressin for treating nocturia in men.

Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P.

BJU Int. 2018 Feb 28. doi: 10.1111/bju.14183. [Epub ahead of print] Review.

PMID:
29489052
15.

Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review.

MacDonald R, Brasure M, Dahm P, Olson CM, Nelson VA, Fink HA, Risk MC, Rwabasonga B, Wilt TJ.

Aging Male. 2018 Feb 2:1-11. doi: 10.1080/13685538.2018.1434503. [Epub ahead of print]

PMID:
29394114
16.

The challenge with systematic reviews of non-randomised studies in urology.

Dahm P, Jung JH, Morgan RL.

BJU Int. 2018 Feb;121(2):161-162. doi: 10.1111/bju.14105. No abstract available.

PMID:
29359531
17.

A Blast from the Past-Back to the 1970s.

Dahm P, Sultan S, Murad MH.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1500-1501. doi: 10.1164/rccm.201711-2186LE. No abstract available.

PMID:
29345971
18.

Medical Expulsive Therapy for Distal Ureteral Stones: The Verdict is In.

Dahm P, Sukumar S, Hollingsworth JM.

Eur Urol. 2017 Nov 23. pii: S0302-2838(17)30986-7. doi: 10.1016/j.eururo.2017.11.010. [Epub ahead of print] No abstract available.

PMID:
29174467
19.

Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Jung JH, Kim J, MacDonald R, Reddy B, Kim MH, Dahm P.

Cochrane Database Syst Rev. 2017 Nov 22;11:CD012615. doi: 10.1002/14651858.CD012615.pub2. Review.

PMID:
29161773
20.

Desmopressin for treating nocturia in men.

Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P.

Cochrane Database Syst Rev. 2017 Oct 21;10:CD012059. doi: 10.1002/14651858.CD012059.pub2. Review.

PMID:
29055129
22.

Future of screening for prostate cancer.

Dahm P.

BMJ. 2017 Sep 19;358:j4200. doi: 10.1136/bmj.j4200. No abstract available.

PMID:
28928226
23.

What does expert opinion in guidelines mean? a meta-epidemiological study.

Ponce OJ, Alvarez-Villalobos N, Shah R, Mohammed K, Morgan RL, Sultan S, Falck-Ytter Y, Prokop LJ, Dahm P, Mustafa RA, Murad MH.

Evid Based Med. 2017 Oct;22(5):164-169. doi: 10.1136/ebmed-2017-110798. Epub 2017 Sep 18. Erratum in: BMJ Evid Based Med. 2018 Apr;23 (2):78.

PMID:
28924055
24.

Intravesical electromotive drug administration for non-muscle invasive bladder cancer.

Jung JH, Gudeloglu A, Kiziloz H, Kuntz GM, Miller A, Konety BR, Dahm P.

Cochrane Database Syst Rev. 2017 Sep 12;9:CD011864. doi: 10.1002/14651858.CD011864.pub2. Review.

PMID:
28898400
25.

Advancing Guideline Development in the United States: A Call to Action by the US GRADE Network.

Morgan RL, Sultan S, Murad MH, Mustafa RA, Dahm P, Helfand M, Falck-Ytter Y, Qaseem A.

Am J Med Qual. 2018 Mar/Apr;33(2):117-118. doi: 10.1177/1062860617726855. Epub 2017 Aug 28. No abstract available.

PMID:
28845692
26.

Value of Prostate Cancer Care: New Information on New Therapies Suggest Less is More.

Wilt TJ, Dahm P.

Eur Urol. 2017 Nov;72(5):736-737. doi: 10.1016/j.eururo.2017.05.023. Epub 2017 May 29. No abstract available.

PMID:
28571885
27.

WITHDRAWN: Value of Prostate Cancer Care: New Information on New Therapies Suggest Less is More.

Wilt TJ, Dahm P.

Eur Urol. 2017 May 20. pii: S0302-2838(17)30402-5. doi: 10.1016/j.eururo.2017.05.012. [Epub ahead of print]

PMID:
28535949
28.

Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.

Kunath F, Schmidt S, Krabbe LM, Miernik A, Dahm P, Cleves A, Walther M, Kroeger N.

Cochrane Database Syst Rev. 2017 May 9;5:CD012045. doi: 10.1002/14651858.CD012045.pub2. Review.

PMID:
28485814
29.

Alvimopan for recovery of bowel function after radical cystectomy.

Sultan S, Coles B, Dahm P.

Cochrane Database Syst Rev. 2017 May 2;5:CD012111. doi: 10.1002/14651858.CD012111.pub2. Review.

PMID:
28462518
30.
31.

Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions.

Dahm P, Oxman AD, Djulbegovic B, Guyatt GH, Murad MH, Amato L, Parmelli E, Davoli M, Morgan RL, Mustafa RA, Sultan S, Falck-Ytter Y, Akl EA, Schünemann HJ.

J Clin Epidemiol. 2017 Jun;86:129-139. doi: 10.1016/j.jclinepi.2017.02.019. Epub 2017 Apr 1.

PMID:
28377194
32.

Re: Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression: S. R. Shim, K. J. Kanhai, Y. M. Ko and J. H. Kim J Urol 2017;197:465-479.

Narayan V, Jung JH, Dahm P.

J Urol. 2017 Jul;198(1):215-216. doi: 10.1016/j.juro.2017.02.3337. Epub 2017 Mar 29. No abstract available.

PMID:
28365370
33.

A core outcome set for localised prostate cancer effectiveness trials.

MacLennan S, Williamson PR, Bekema H, Campbell M, Ramsay C, N'Dow J, MacLennan S, Vale L, Dahm P, Mottet N, Lam T; COMPACTERS Study Group.

BJU Int. 2017 Nov;120(5B):E64-E79. doi: 10.1111/bju.13854. Epub 2017 May 3.

34.

Similar prostate cancer and all-cause mortality in men with localised prostate cancer undergoing surgery or radiation therapy versus active monitoring at 10 years of follow-up.

Dahm P, Ilic D, Wilt T.

Evid Based Med. 2017 Jun;22(3):93. doi: 10.1136/ebmed-2016-110634. Epub 2017 Mar 3. No abstract available.

PMID:
28258067
35.

Raising the bar for systematic reviews with Assessment of Multiple Systematic Reviews (AMSTAR).

Dahm P.

BJU Int. 2017 Feb;119(2):193. doi: 10.1111/bju.13754. No abstract available.

36.

Moving from Consensus- to Evidence-Based Clinical Practice Guidelines for Peyronie's Disease.

Dahm P, Jung JH, Bodie J.

J Sex Med. 2017 Jan;14(1):170-171. doi: 10.1016/j.jsxm.2016.10.015. No abstract available.

PMID:
28065352
37.

In localized prostate cancer, active monitoring, prostatectomy, and radiotherapy did not differ for 10-y cancer deaths.

Dahm P, Wilt T.

Ann Intern Med. 2016 Dec 20;165(12):JC63. doi: 10.7326/ACPJC-2016-165-12-063. No abstract available.

PMID:
27992919
38.

In prostate cancer, urinary and sexual function were worse with prostatectomy than active monitoring or radiotherapy.

Dahm P, Wilt T.

Ann Intern Med. 2016 Dec 20;165(12):JC62. doi: 10.7326/ACPJC-2016-165-12-062. No abstract available.

PMID:
27992918
39.

Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis.

Hollingsworth JM, Canales BK, Rogers MA, Sukumar S, Yan P, Kuntz GM, Dahm P.

BMJ. 2016 Dec 1;355:i6112. doi: 10.1136/bmj.i6112. Review.

40.

Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.

Dahm P, Brasure M, MacDonald R, Olson CM, Nelson VA, Fink HA, Rwabasonga B, Risk MC, Wilt TJ.

Eur Urol. 2017 Apr;71(4):570-581. doi: 10.1016/j.eururo.2016.09.032. Epub 2016 Oct 4. Review.

41.

The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality.

Han JL, Gandhi S, Bockoven CG, Narayan VM, Dahm P.

BJU Int. 2017 Apr;119(4):638-649. doi: 10.1111/bju.13653. Epub 2016 Oct 17.

42.

Improved Reporting of Randomized Controlled Trials in the Urologic Literature.

Narayan VM, Cone EB, Smith D, Scales CD Jr, Dahm P.

Eur Urol. 2016 Dec;70(6):1044-1049. doi: 10.1016/j.eururo.2016.07.042. Epub 2016 Aug 5.

PMID:
27503840
43.

Letter to the editor: Korean clinical practice guideline for benign prostatic hyperplasia.

Jung JH, Dahm P.

Investig Clin Urol. 2016 Jul;57(4):303-4. doi: 10.4111/icu.2016.57.4.303. Epub 2016 Jul 6. No abstract available.

45.

Editorial Comment.

Dahm P.

J Urol. 2016 Oct;196(4):998. doi: 10.1016/j.juro.2016.04.102. Epub 2016 Jun 28. No abstract available.

PMID:
27368142
46.

Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostaic Hyperplasia: A Review [Internet].

Brasure M, MacDonald R, Dahm P, Olson CM, Nelson VA, Fink HA, Risk M, Rwabasonga B, Wilt TJ.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 May.

47.

The jury on posterior muscolofascial reconstruction is still out.

Dahm P.

BJU Int. 2016 Jul;118(1):10-1. doi: 10.1111/bju.13531. No abstract available.

48.

Postgraduate Education in Quality Improvement Methods: Initial Results of the Fellows' Applied Quality Training (FAQT) Curriculum.

Winchester DE, Burkart TA, Choi CY, McKillop MS, Beyth RJ, Dahm P.

Crit Pathw Cardiol. 2016 Jun;15(2):36-9. doi: 10.1097/HPC.0000000000000073.

PMID:
27183251
49.

The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis.

Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, Konety BR.

World J Urol. 2016 Sep;34(9):1229-37. doi: 10.1007/s00345-016-1772-z. Epub 2016 Feb 4. Review.

PMID:
26847182
50.

Rating the quality of evidence is by necessity a matter of judgment.

Murad MH, Mustafa R, Morgan R, Sultan S, Falck-Ytter Y, Dahm P.

J Clin Epidemiol. 2016 Jun;74:237-8. doi: 10.1016/j.jclinepi.2015.11.018. Epub 2016 Jan 6. No abstract available.

PMID:
26772606

Supplemental Content

Support Center